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Rheumatoid arthritis (RA) is a debilitating autoimmune disease of global prevalence. The disease is characterized by synovial
inﬂammation leading to cartilage and bone damage. Most of the conventional drugs used for the treatment of RA have severe
adverse reactions and are quite expensive. Over the years, increasing proportion of patients with RA and other immune disorders
are resorting to complementary and alternative medicine (CAM) for their health needs. Natural plant products comprise one
of the most popular CAM for inﬂammatory and immune disorders. These herbal CAM belong to diverse traditional systems of
medicine, including traditional Chinese medicine, Kampo, and Ayurvedic medicine. In this paper, we have outlined the major
immunological pathways involved in the induction and regulation of autoimmune arthritis and described various herbal CAM
that can eﬀectively modulatethese immunepathways.Most ofthe informationabout the mechanismsof action ofherbal products
in the experimental models of RA is relevant to arthritis patients as well. The study of immunological pathways coupled with the
emerging application of genomics and proteomics in CAM research is likely to provide novel insights into the mechanisms of
action of diﬀerent CAM modalities.
1.HerbalCAMfortheTreatmentof
Inﬂammatory AutoimmuneArthritis
Conventional (allopathic) anti-inﬂammatory drugs are the
mainstay of treatment for a variety of immune disorders,
including rheumatoid arthritis (RA) [1–5]. The nonsteroidal
anti-inﬂammatory drugs (NSAIDs) and biologics (e.g., anti-
tumornecrosis factor(TNF)-αantibody and thedecoyTNF-
αreceptor) represent aprominent groupofsuch drugs.How-
ever,theusageofthesedrugsisassociated withsevereadverse
eﬀects, including gastrointestinal bleeding and cardiovascu-
lar complications [3, 5, 6]. Owing to the side eﬀects and the
high cost of conventionally used anti-inﬂammatory drugs,
patients with arthritis are increasingly using complementary
and alternative medicine (CAM) modalities of treatment
[7–21]. Over 36% Americans used CAM products annually
for diﬀerent disorders and the trend is on the rise [11,
22–25]. Traditional Chinese medicine, Ayurvedic medicine,
Kampo, and Homeopathy are among the major contributors
to the natural products consumed by patient populations.
However, despite the increasing usage and popularity of
CAM products in the western world [11, 22–26], one of
the main limitations of their use is the meager information
about their mechanisms of action and objectivity in evaluat-
ing eﬃcacy [27, 28]. This also is one of the main reasons for
skepticism about CAM in the minds of both the lay public
and the professionals [25, 29–31]. Thus, there is a need for
continued studies on the mechanistic aspects of action of
CAM products.
A diverse group of diseases is characterized by inﬂam-
mation that can be triggered not only by foreign microbial
antigens but also by self-antigens. The response to self-
antigens results in autoimmune inﬂammation. Therefore,
liketheinfectiousdiseases, theautoimmunediseases(suchas
multiple sclerosis (MS), type-1 diabetes mellitus (T1D), RA,
and atherosclerosis) are also associated with inﬂammation.
Considering that autoimmune diseases result from a dysreg-
ulated immune system [36, 37], it is imperative to examine
and unravel the immunological basis of the therapeutic
activity of CAM products against autoimmune disorders as
well as other conditions involving inﬂammation [27, 28,
38–42]. This paper is focused on the immunomodulation2 Evidence-Based Complementary and Alternative Medicine
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Figure 1:Experimentally-induced adjuvantarthritis(AA) intheLewis rat.(a)Arthritic pawsand(b)thecourseofthedisease.AAisinduced
by subcutaneous immunization with heat-killed M. tuberculosis H37Ra (1mg/rat) [32–34]. The phases of AA are as follows: incubation,
onset, peak, and recovery. The Arthritic Score represents the severity of arthritis [35]. Each paw is graded on a scale of 0 to 4, and total score
per rat is derived by adding the scores of all 4 paws of that rat [32–34].
of autoimmune arthritis by herbal CAM products. We have
described here in detail adjuvant arthritis (AA) (Figure 1)
as a prototypic experimental model of RA. Conceptually,
the main immune eﬀe c t o rp a t h w a y si nA Aa r eb r o a d l yr e p -
resentative of various other animal models of arthritis, for
example, collagen-induced arthritis (CIA), streptococcal cell
wall-induced arthritis (SCWIA), and proteoglycan-induced
arthritis. We have elaborated upon speciﬁc immune path-
ways in arthritis that are modulated by a variety of herbal
preparations originating from plants native to diﬀerent
regions of the world (Table 1,a n dF i g u r e s2 and 3). These
immune mechanisms include the cellular and humoral
responses, the cytokine response/balance, and the cellular
migration into the target organ.
Theabove-mentionedimmunologicaleventsinthepath-
ogenesis of arthritis also oﬀer many promising targets for
therapeutic intervention (Figures 2 and 3). We recommend
that these and other customized immune parameters be
considered for testing besides various biochemical and
pharmacological parameters for the evaluation of the mech-
anisms of action of herbal CAM products. The herbal CAM
shown in Table 1 are representative of those tested for the
modulation of immunological events that contribute to
their antiarthritic activity in vivo in experimental models
of arthritis. Understandably, there are several other natural
products that possess antiarthritic activity, but their eﬀects
on the immune system have not yet been tested. Given the
scope of this paper on immune modulation, we have
excluded most of those products from Table 1.
2.RheumatoidArthritis
RA is prevalent (0.8%) throughout the world and aﬀects
all races [5, 84]. Women are aﬀected approximately three
times more often than men. The age of onset is between
late twenties and early ﬁfties, but no age is immune to the
disease.Inchildrenandyoungadults,thediseasemanifestsas
juvenile chronic arthritis (JCA). RA is a chronic multisystem
disease characterized by persistent inﬂammatory synovitis
usually involving peripheral joints in a symmetric distribu-
tion[5,85].Thesynovial inﬂammation, ifuncontrolled,may
lead to cartilage damage, bone erosions, and ankylosis of the
aﬀected joints [5]. Twin studies and family studies indicate
that there is a genetic predisposition to RA [86], and about
70% of patients have HLA-DR4 or -DR1 alleles or both. The
precise target autoantigen for RA has not yet been identiﬁed.
Type II collagen (CII), aggrecan, immunoglobulin binding
protein (BiP),and heat-shock protein65 (Hsp65)are among
the antigens that have been implicated in the pathogenesis of
RA[5,85].As mentionedabove,NSAIDSare themainstay of
therapy for a large proportion of patients with RA. However,
because of adverse reactions, high costs, and limited eﬃcacy
of these drugs in many patients [3–5], the use of CAMby RA
patients is becoming increasingly popular in USA and other
developed countries [9, 10, 13, 14, 16, 20].
3.AdjuvantArthritis:
An ExperimentalModel ofRA
A Ac a nb ei n d u c e di nt h eL e w i s( R T . 1 l) rat by immunization
with heat-killed Mycobacterium tuberculosis (Mtb) (H37Ra)
[87]. The disease manifests as inﬂammation of the paws
including the paw joints. The paw inﬂammation aﬀects
primarily the ankles, wrists, and smaller joints. The arthritic
inﬂammation starts after 8–10 days, peaks between day 15–
17, and then undergoes a spontaneous, gradual recovery in
the subsequent 12–15 days (Figure 1). The primary immune
reaction in paw joints is the mononuclear cell inﬁltrationEvidence-Based Complementary and Alternative Medicine 3
Table 1: Mechanisms of immunomodulationby herbal products.
Herbs Origin Reference
(A) Cellular and humoralresponses
(A.1) Eﬀect on T cell response (T cell activation, T cell proliferation,
ratio of CDa4/CD8 cells, etc.)
Pterodon pubescens Brazil [45]
Chrysanthemum indicum, Fumigant Ib, Huo-Luo-Xiao-Ling Danb,
Litsea coreana, Radix Linderae, Tripterygium wilfordii
China [34, 46–52]
Dai-bofu-tob, Stephania tetrandra Japan [53, 54]
Centella asiatica Southeastern Asia/China [55]
(A.2) Induction/expansion of regulatory T cells
Chelidonium majus Korea [56]
Triptolide (Tripterygium wilfordii) China [57]
(A.3) Change in antibody/B cell response
Pterodon pubescens Brazil [45]
Camellia sinensis, Curcumin, Celastrus aculeatus,
Huo-Luo-Xiao-Ling-Danb, Pomegranate extract, Radix Linderae
China, Korea [33, 34, 50, 58–61]
Stephania tetrandra Japan [54]
Barrington racemosa India [62]
Centella asiatica Southeastern Asia/China [55]
Taxus brevifolia, Fumagillin analogue North America [63, 64]
(B) Cytokineresponse/balance
(B.1) Aﬀecting major cytokines produced by
macrophages/antigen-presenting cells (TNF-α,I L - 1 ,I L - 6 ,et c . )a n d / o r
deviation of the response to Th2 type
Nyctanthes arbor-tristis, Swertia chirayita India [65, 66]
Zingiber oﬃcinale India/China [67]
Boswellia carterii, Camellia sinensis, Cherriesb,F u m i g a n tI b,
Curcumin, Huo Luo-Xiao-Ling-Danb, Litsea coreana, Paeonia
lactiﬂora, Plectranthus amboinicus, Pomegranate extract, Sinomenium
acutum,Q F G J S b, Tripterygium wilfordii, Turpinia Arguta
China, Korea, India [47–49, 51, 52, 59–61, 68–75]
Chelidonium majus, PG201, Ulmus davidiana Korea [56, 76, 77]
(B.2) Inhibiting the pathogenic cytokine IL-17 and related cytokines
Camellia sinensis, Huo-Luo-Xiao-Ling-Danb, Tripterygium wilfordii China [33, 34, 52, 59]
(C) Cellularmigrationintothetarget organ
(C.1) Aﬀecting the expression of chemokines and adhesion molecules in
the blood vessels or joint tissues
Fumigant Ib China [49]
(C.2) Altering the migration of leukocytes into the tissues-monocytes,
macrophages, neutrophils, lymphocytes, etc.
Curcuma longa India/China [78, 79]
Pterodon pubescens Brazil [45]
Camellia sinensis China [59]
Centella asiatica Southeastern Asia/China [55]
(D) Mechanismofactionnotyet determined
Bai jiang caob, Duhuob,S a n q u i b,Y a nh us u o b China [80]
Chlorophytum borivilianum, Ocimum sanctum India [81, 82]
Shu-Jing-Huo-Xue-Tangb Japan [83]
The mechanisms of immunomodulation by herbs were studied using various experimental rodent models of human rheumatoid arthritis, for example,
adjuvant arthritis (AA), Collagen-induced arthritis (CIA), and streptococcal cell wall-induced arthritis (SCWIA).
aCD: Cluster of diﬀerentiation; IL: Interleukin; TNF-α: Tumor-necrosis factor-alpha.
bHerbal mixtures.4 Evidence-Based Complementary and Alternative Medicine
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Figure 2: A schematic overview of the immunological eﬀector mechanisms that mediate the antiarthritic activity of diﬀerent herbal CAM
modalities. The herbal products inﬂuence the number and/or activity of speciﬁc immune mediators (e.g., T cells, antibodies, cytokines,
and chemokines), which in turn drive the 3 major immune pathways leading to pathological damage observed in arthritis [5, 43, 44].
These pathways include cellular and humoral immune responses, cytokine response/balance, and cell migration. The net eﬀect of these
immunological changes induced by herbal treatment is the suppression of inﬂammatory and related arthritic processes [5, 43, 44]. The
names and geographical origin of speciﬁc plant products that induce these changes are listed in Table 1.
of the synovial tissue, which if uncontrolled, can lead to
damage to cartilage and bone [87]. Mycobacterial hsp65
(Bhsp65) has been invoked in the pathogenesis of AA.
Following Mtb injection, Bhsp65 is taken up by the regional
draininglymphnodeswhere antigen-presenting cells(APCs)
process and present this antigen to na¨ ıve T cells (Figure 3).
The T cells bearing receptors speciﬁc for epitopes within
Bhsp65 then get activated and undergo proliferation. These
antigen-primed T cells then leave the lymph nodes to enter
intotheperipheralcirculation.TheseTcellsthenmigrateout
from the blood vessels into the target organ, the joint, where
theyinitiate theimmune pathology(Figure 3).RatAAshares
several features with human RA, and thereby, it serves as an
excellent model for RA [87].
The AA model has extensively been used for studies
regarding the pathogenesis of autoimmune arthritis [32, 43,
88, 89]a sw e l la sf o rt h et e s t i n go fn e wn a t u r a l[ 33, 34, 58]
or synthetic antiarthritic therapeutic products. A variety of
herbal CAM products have been shown to attenuate the
severity of the disease in the rat AA model (Table 1).
These herbs modulate diﬀerent immunological eﬀector and
regulatory pathways (discussed below in detail) involved in
the disease process (Figures 2 and 3). Another model of
chronic inﬂammation leading to bone loss has also been
employed to examine the role of natural products (e.g.,
green tea) in limiting bone damage and bone loss, which
accompanies chronic arthritis [90, 91].
4.Heat-ShockProteins(Hsps) Serveas
the TargetAntigensinAutoimmuneArthritis
Hsps have been associated with many autoimmune diseases
such as RA, Crohn’s disease, MS, and systemic lupus
erythematosus (SLE) [92]. Hsps may also induce protection
against arthritis [93].Mosthspsareacutestress reactantsthat
insure cell survival under hostile conditions. They also are
the molecular chaperones involved in protein folding and
other functions for maintaining the structural integrity of
other proteins [92]. A T-cell clone that was arthritogenic
f o rt h eL e w i sr a tw a sf o u n dt ob es p e c i ﬁ cf o rt h ee p i t o p e
180–188 (p180–188) of Bhsp65 [88]. In juvenile chronic
arthritis (JCA) patients, there was T-cell reactivity to p180–
188 of Bhsp65, as well as to the partially homologous
determinant within articular cartilage link protein [94]. The
T cells of these patients also showed signiﬁcant response to
human hsp60 [95]a n dB h s p 6 5[ 94, 96], emphasizing the
importance ofHsp65as oneofthemajor antigensin arthritis
pathogenesis. Other hsps, including hsp70 and hsp47 have
also beeninvokedinthepathogenesisofAA[97].SimilaritiesEvidence-Based Complementary and Alternative Medicine 5
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Figure 3:HerbalCAM caninterveneatmultiplesteps inthe pathogenesisofautoimmunearthritis.Experimental arthritis canbe induced in
susceptible rodent strains by subcutaneous (s.c.), intradermal (i.d.), or intraarticular injection of an arthritogen (e.g., Mtb, type II collagen,
streptococcal cell wall,etc.).Theantigensthatareinjected s.c.ori.d. aredirected intothedraininglymphnodeswheretheimmuneresponses
involvingthe antigen-presenting cells, T cells, andB cells are initiated. The activated lymphocytes and otherleukocytes then migrateinto the
joints and initiate arthritic inﬂammation via a variety of soluble mediators, including proinﬂammatory cytokine and antibodies (Figure 1).
Herbal CAM can inhibit the initiation and progression of inﬂammatory arthritis by inﬂuencing multiple pathways involved in the disease
process. Speciﬁc herbs that interfere with particular immune pathway are described in Table 1.
in immune response to disease-related antigens in rodent
models and humans have provided useful insights into the
disease pathogenesis.
It has been shown that natural plant products such as
ﬂavonoids and Celastrol can alter the cellular expression of
hsps [98–100]. These observations are potentially of signif-
icance in view of the observed disease-protective eﬀects of
green tea ﬂavonoids[33] and the ethanol extract of Celastrus
[58]. However, the precise mechanistic link between the two
sets of observations remains to be fully deﬁned. In regard to
the modulation of antigen-speciﬁc T-cell response to hsps by
CAM modalities, we have shown that feeding of the Chinese
herbal formula Huo Luo Xiao Ling (HLXL) dan to Lewis
rats signiﬁcantly reduced the T-cell proliferative response to
Bhsp65 [34], and this eﬀect was associated with suppression
of arthritis. On the contrary, feeding of rats with green
tea extract [33]o rC e l a s t r u s[ 58] failed to inﬂuence T-cell
proliferativeresponsetoBhsp65despitesigniﬁcantreduction
in the severity of AA. However, as described below, these rats
showed signiﬁcant changes in cytokine response to Bhsp65
but without any change in T-cell proliferation, revealing
a dichotomy of the two immune parameters. In support of
our results, several other natural products (e.g., Quercetin,
Resveratrol, Kaempferol, Vineatrol) have also been reported
to inﬂuence lymphocyte proliferative responses, with most
of them leading to inhibition of proliferative response [101–
103]. Also reported is the dissociation between proliferation
and function of lymphocytes exposed to natural products
like Kaemferol [103].
5.CD4+CD25+ T-RegulatoryCells(Treg)Are
VitalforSelf-Tolerance andRegulationof
Autoimmunity
Many types of regulatory T cells, including Th2, Th3, Treg,
NKT cells, and Tr1 have been described [104]. The most
recent addition to the group of regulatory T cells is the
CD4+CD25+ T-regulatory cell (Treg) [105–107]. Treg have
emerged asthecentral controllersofautoimmunity in a vari-
ety of experimental models of human autoimmune diseases
[105–107]. Importantly, in animal models, CD4+CD25+ T-
cell therapy via adoptive transfer of cells can eﬀectively delay6 Evidence-Based Complementary and Alternative Medicine
and suppress a variety of immunological diseases including
diabetes,colitis, andgastritis [105–107].Onthecontrary, the
in vivo depletion of Treg leads to the early initiation and/or
aggravation of autoimmune arthritis [106–109]a sw e l la s
other autoimmune diseases.
There are two distinct types of Treg: the “natural Treg”
that developed in the thymus and the “adaptive (induced)
Treg” that developed in the periphery in response to antigen
exposure [106]. The mechanism of action of Treg involves
cell-cell contact between Treg and the responder cells, and
it requires activation of Treg via the T-cell receptor (TCR)
[105–107]. Secreted TGF-β and IL-10 have been suggested to
mediate suppression by Treg in vivo.
There is evidence for a reciprocal control of the diﬀeren-
tiation ofT helper 17 (Th17) and Treg. The diﬀerentiationof
the proinﬂammatory and pathogenic Th17 cells is induced
by the simultaneous presence of TGF-β and IL-6, whereas
t h ep r e s e n c eo fT G F - β alone induces the generation of Treg
expressing the transcription factor Foxp3 [110].
Over the last 5–10 years, the signiﬁcance of determining
thefrequencyandsuppressive functionofTregforevaluating
the autoimmune disease process as well as assessing the
eﬃcacy of therapeutic products for diﬀerent autoimmune
diseasesis increasinglybeingrealized[105–107,111].Defects
in Treg have been reported in RA [112], and this reduced
activity of Treg can be restored following successful therapy,
for example, with anti-TNF-α i nt h ec a s eo fR A[ 112].
A recent study in the area of transplantation research has
shown that dendritic cells treated with triptolide (derived
from the Chinese herb Tripterygium wilfordii)p r o m o t e st h e
expansion of Treg in vitro [57]. It is hoped that assessment of
Treg number and function would be incorporated regularly
in studies aimed at deﬁning the mechanisms of action of
various CAM modalities, including natural plant products.
Also, as described above, there are various other types of
regulatory T cells besides Treg [104]. It is likely that diﬀerent
CAM modalities might have diﬀerential eﬀect on distinct
subsets of regulatory T cells, such that one product may have
am o r ep r o n o u n c e de ﬀect on Treg, while the other might
instead have a major eﬀect on Th2 or Tr1 type of regulatory
cells.
6. AntibodiesContributeto thePathogenesis of
Autoimmune Arthritis
Studies in a spontaneous model of autoimmune arthritis
have underscored the importance of antibodies in mediat-
ing the immune pathology in this disease; the pathology
is initiated by T cells but subsequently perpetuated by
antibodies [113]. Studies in the CIA model in mice have
clearly demonstrated the importance of antibodies to type II
collagen (CII) in the disease process [114]. However, at this
time there is not much information about the physiologic
role of antibodies to hsp65 in AA. The pathogenic eﬀect
of anti-Bhsp65 antibodies in AA has not been excluded
formally. On the contrary, there is evidence from work done
by other investigators and us [35, 115]p o i n t i n gt ot h e
protectiveeﬀectagainstAAofanti-Bhsp65antibodies.Inone
study, the AA-protectiveeﬀectof anti-Bhsp65 antibodies was
attributedtotheproductionofIL-10frommononuclearcells
[115].
IntheCIAmodel, extracts ofgreentea[59]pom egran at e
[60], and Taxol [63, 64] have been shown to suppress
arthritis, and this eﬀect was associated with a signiﬁcant
decrease in anti-CII antibodies. A similar eﬀect on the
clinical disease, the proinﬂammatory cytokines, and the
serumIgG2awasreportedinanotherstudyonCIAfollowing
treatment with curcumin, a major component of turmeric
[61]. Turmeric extract has also been shown to induce
protection against arthritis in streptococcal cell wall-induced
arthritis model of RA [78]. In one of our studies based on
the AA model, we observed that feeding the polyphenolic
extract of green tea to Lewis rats resulted in a signiﬁcant
decrease in the antibody response to Bhsp65 [33]. Similar
results were obtained with a traditional Chinese medicine,
HLXL, which is a mixture of 11 diﬀerent herbs [34]. In
both cases, the decrease in antibody response was associated
with a corresponding reduction in the severity of arthritis.
However, not all antiarthritic herbs tested by us caused
a decrease in antibody response to Bhsp65. In another
study, we observed the opposite as the feeding of Celastrus
to Lewis rats led to an increased anti-Bhsp65 antibody
response despite a signiﬁcant suppression of clinical arthritis
[58].
At present, we do not have additional information to
clarify the diﬀerences in the functional attributes of the
antibody subsets that are predominantly altered following
feeding of diﬀerent plant products. However, we propose
that anti-Bhsp65 antibodies produced during the course
of AA in the Lewis rats belong to two main categories,
pathogenic and protective [35]. In this context, we suggest
that diﬀerent herbs target distinct subsets of antibodies such
that reduction in clinical arthritis might involve either the
suppression of pathogenic antibodies or the enhancement
of protective antibodies, or both. Furthermore, studies of
antibody patterns using a panel of antigens [40, 41]t a r g e t e d
in arthritis and other autoimmune diseases might provide a
useful readout for the eﬀect of CAM products on the disease
process.
7.RegulationofAutoimmunityvia T-Helper
(Th1)-/Th2-TypeCytokineBalance
Proinﬂammatory cytokines TNF-α,I L - 1 β,a n dI L - 6p r o -
duced by macrophages and other immune cells are of critical
importance in the initiation and propagation of arthritis
[116, 117]. Among the T cell, the Th1 cells secrete IFN-
γ and TNF-α, whereas the counter-regulatory Th2 cells
secrete IL-4, IL-5, IL-10, and IL-13 [118]. Th1 cells are
primarily involved in the pathogenesis of certain organ-
speciﬁc autoimmunediseases, whereas Th2 cellsplaya major
role in systemic autoimmunity. The role of Th1-Th2 balance
in regulation of autoimmunity has been validated through
several animal model studies. The susceptibility or resistance
to disease [119] and protection from disease [120], as well
as improvement of the disease in RA patients [117]w a sEvidence-Based Complementary and Alternative Medicine 7
associatedwithachangeincytokinebalancetoTh2type.The
change in Th1/Th2 balance could occur either by a decrease
in the proinﬂammatory cytokine (e.g., IFN-γ)o ra ni n c r e a s e
in the anti-inﬂammatory cytokine (e.g., IL-4/IL-10), or both
[42, 118].
In a study on CIA, activation of the Th2 response was
showntoinhibitIFN-γ productionaswellasreductioninthe
severity of arthritis [121]. Other investigators have reported
the downmodulation of CIA coupled with suppression of
proinﬂammatory cytokines (e.g., TNF-α,I L - 1 β,a n dI L -
6) by treatment of mice with extracts of green tea [59],
pomegranate [60],orPlectranthus amboinicus[68].Asimilar
eﬀect has been observed in vitro with Moutan cortex [122].
In3separatestudiesinAAusingdiﬀerentnaturalplantprod-
ucts, namely, Celastrus [58], green tea [33], and HLXL [34],
we observed that each ofthese three herbal productsinduced
protectionagainstAAcoupledwithanalteredTh1/Th2ratio.
The latter eﬀect was caused primarily by an increase in IL-10
while IFN-γ remained unchanged. Enigmatically, it has also
been observed that proinﬂammatory Th1 cytokines such as
IFN-γ and TNF-α might display dual roles as inﬂammatory
and immunosuppressive cytokines [123]. For example, the
suppression of inﬂammation by IFN-γ has been observed in
AA [123]. Therefore, herbal CAM-induced changes in the
level of certain cytokines with dual functions need to be
evaluated with caution.
8.T-Helper17 (Th17)CellsMediate
InﬂammationandTissueDamageinArthritis
Th17cellssecreteIL-17,whichhasbeenshowntobeinvolved
in inﬂammatory and autoimmune diseases [110, 124]. Th17
subset of T cells is distinct from Th1 and Th2 cells, and the
diﬀerentiation of Th17 cells is induced by the concurrent
exposure to TGF-β and IL-6 [110]. Retinoic acid-related
orphan receptor gamma-t (RORγt) is the transcription
factor required for the diﬀerentiation of Th17 cells. IFN-
γ,I L - 2 ,I L - 4 ,a n dI L - 2 7h a v eb e e ns h o w nt oi n h i b i tt h e
activity of Th17 cells, whereas IL-21 and IL-23 are important
for the clonal expansion and stabilization (maintenance)
of Th17 cells [110]. IL-17 has been implicated in the
pathogenesis of autoimmune diseases including arthritis
[125]. Abundant quantities of IL-17 have been found in the
synovial ﬂuid of RA patients [125]. The in vivo blockade of
IL-17 by soluble IL-17 receptors or by neutralizing anti-IL-
17 antibody can signiﬁcantly attenuate arthritis in rodents
[126]. Furthermore, mice deﬁcient in IL-17 [127]o rI L - 1 7
receptor [128] were found to be resistant to the induction of
CIA.
In the preceding section, we have summarized the results
of our earlier studies showing that a shift in Th1 to Th2
ratio induced by natural plant products was associated with
r e d u c e ds e v e r i t yo fA Ai nL e w i sr a t s[ 33, 34, 58]. In two of
these studies, we also tested the IL-17 response. Importantly,
feeding rats with green tea [33]o rH L X L[ 34]l e dt oa
signiﬁcant reductioninIL-17response. Thus, theconcurrent
changes in Th1/Th2 ratio and IL-17 response culminated
into a beneﬁcial antiarthritic activity of green tea and HLXL.
9.Chemokinesand AdhesionMolecules
Orchestrate the Migrationof Leukocytesinto
the TargetOrganin Arthritis
The migration of lymphocytes, macrophages, and other cells
from blood into the joints is orchestrated by deﬁned interac-
tions mediated by chemokines and adhesion molecules [129,
130]. Chemokines are chemoattractant cytokines that direct
the migration ofleukocytesfrom blood vessel lumeninto the
target site of inﬂammation in the periphery. The expression
of chemokines and their receptors is inﬂuenced by cytokines
and other inﬂammatory mediators. Dysregulated expression
of chemokines and/or their receptors may lead to immune
pathology. The blocking or neutralization of these molecules
via antagonists or antibodies is being explored for the
treatment of arthritis in experimental models [131, 132]a n d
RApatients[133,134].Thus,studyofthelevelsofexpression
of diﬀerent chemokines and adhesion molecules, and the
blockade of these biomolecules by appropriate reagents can
serve as an important tool for deﬁning the mechanisms of
actions of CAM products that have antiarthritic activity.
Many herbal products have been reported to modulate
the expression of speciﬁc chemokines in diﬀerent tissues
[135–142], and many of these chemokines are relevant for
the traﬃcking of leukocytes into the joints in arthritis as
well [129, 130]. In one of our studies, we reported a simple
method to study the in vivo migration of radiolabeled
leukocytes in vivo [44]. We also showed a clear association
between the kinetics of migration of leukocytes through the
joints and the susceptibility to AA [44]. The radiolabel can
be replaced by a ﬂuorescent dye as needed for future use of
such assays in CAM studies.
10.ConcludingRemarks
This paper is focused on cellular and humoral immuno-
logical eﬀector mechanisms that mediate the action of a
wide variety of herbal CAM for the treatment of exper-
imental autoimmune arthritis. However, natural products
can contribute to the suppression of inﬂammation and
arthritic processes via altering speciﬁc molecular mediators
of these pathways. For example, the antiarthritic activity of
variouscompounds(Teapolyphenols,Boswellicacid,Morin,
etc.) puriﬁed from natural products has been attributed
in part to their anti-oxidant activity [33, 59]a n dt o
their action on nuclear factor-kB (NF-kB), cyclooxygenase-
2 (COX-2), 5-lipoxygenase (5-LOX), and matrix metallo-
proteinases (MMPs) (reviewed in [18]). Therefore, future
studies on herbal products would beneﬁt from including test
parameters that span across pathological, immunological,
biochemical, and molecular biology-related aspects of the
disease process. For immunological aspects, we hope to see
more CAM studies both in vitro and in vivo on the newer
cytokines (e.g., the IL-17/IL-23 axis) and Treg. Furthermore,
the study of genomics and proteomics of CAM [143–145]
is representative of several modern research tools whose
investment in CAM research is currently underway. This
in turn would not only enhance the depth and scope8 Evidence-Based Complementary and Alternative Medicine
of investigations into CAM research, but also provide an
interface where CAM and conventional medicine could ﬁnd
a common ground for understanding the mechanisms of
action of therapeutic products and their practical use for the
ultimate beneﬁt ofthe patients. Itis ratherdiﬃcult to predict
withcertaintythenaturalproductsorcompoundsthatmight
end up as successful therapeutic agents for RA. Nevertheless,
on the basis of the results obtained from animal models of
RA as well as the delineation of multiple immunological
and molecular targets of the indicated herbal products,
we ﬁnd Tea polyphenols, Celastrol, Triptolide, Curcumin,
Boswellic acids, and HLXL as promising candidates for
further preclinical and clinical trials in RA.
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